会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHOD OF MANUFACTURING PRINTED CIRCUIT BOARD
    • 制造印刷电路板的方法
    • US20090280239A1
    • 2009-11-12
    • US12425792
    • 2009-04-17
    • Shigenori MORITATakashi ODANaoko YOSHIDA
    • Shigenori MORITATakashi ODANaoko YOSHIDA
    • H05K3/00
    • H05K3/107H05K3/182H05K2203/0108H05K2203/0338H05K2203/0709
    • First, a catalyst for performing electroless plating in a subsequent step is caused to adhere to surfaces of uneven portions of a matrix. Next, an insulating layer made of a resin material is prepared. Then, the insulating layer is heated to be softened while the uneven portions of the matrix are pressed against one surface of the insulating layer. Thus, grooves corresponding to shapes of the uneven portions of the matrix are formed in the insulating layer while the catalyst is transferred to bottom surfaces and side surfaces of the grooves. The insulating layer is then subjected to electroless plating. In this case, metal is deposited by reduction reaction on portions of the insulating layer where the catalyst exists. Accordingly, conductor traces are formed in the grooves of the insulating layer.
    • 首先,在随后的步骤中进行无电镀的催化剂附着在基体的不均匀部分的表面。 接着,制备由树脂材料制成的绝缘层。 然后,将绝缘层加热软化,同时将基体的不均匀部分压在绝缘层的一个表面上。 因此,在催化剂转移到槽的底面和侧面的同时,在绝缘层中形成对应于矩阵的不平坦部分的形状的凹槽。 然后对绝缘层进行化学镀。 在这种情况下,通过还原反应将金属沉积在存在催化剂的绝缘层的部分上。 因此,导体迹线形成在绝缘层的沟槽中。
    • 3. 发明授权
    • Electrolyte for driving electrolytic capacitor and electrolytic
capacitor using the same
    • 用于驱动电解电容器和电解电容器的电解液
    • US5776358A
    • 1998-07-07
    • US732372
    • 1997-05-02
    • Nario NiiboNaoko YoshidaYoshinori Takamuku
    • Nario NiiboNaoko YoshidaYoshinori Takamuku
    • H01G9/035H01G9/02H01G9/022
    • H01G9/022
    • The invention relates to an electrolyte for driving electrolytic capacitor and an electrolytic capacitor using the same, and by preparing by using a solvent mainly composed of organic compound, and dissolving one or more solutes selected from the group consisting of inorganic acids and organic acids, more specifically adding and dissolving at least one of copolymers of polyethylene glycol and polypropylene glycol shown in formulas (1) and (2), or both of the copolymers of polyethylene glycol and polypropylene glycol shown in formulas (1) and (2) simultaneously, the spark generation voltage and chemical conversion factor of formed oxidation film are enhanced, thereby improving the reliability of the electrolytic capacitor.HO--(C.sub.2 H.sub.4 O).sub.n --(C.sub.3 H.sub.6 O).sub.m--(C.sub.2 H.sub.4 O).sub.n --H (1) (n and m are arbitrary natural numbers.) HO--�(C.sub.2 H.sub.4 O).sub.n --(C.sub.3 H.sub.6 O).sub.m !.sub.i --H(2) (n, m, and 1 are arbitrary natural numbers.)
    • PCT No.PCT / JP96 / 00473 Sec。 371日期:1997年5月2日 102(e)日期1997年5月2日PCT提交1996年2月29日PCT公布。 第WO96 / 27201号公报 日期1996年9月6日本发明涉及一种用于驱动电解电容器的电解质和使用其的电解电容器,并且通过使用主要由有机化合物组成的溶剂制备,并溶解一种或多种选自无机酸的溶质 和有机酸,更具体地加入和溶解式(1)和(2)所示的聚乙二醇和聚丙二醇的共聚物中的至少一种,或式(1)和(2)所示的聚乙二醇和聚丙二醇的共聚物, 2)同时,提高了形成的氧化膜的火花发生电压和化学转化率,从而提高了电解电容器的可靠性。HO-(C2H4O)n-(C3H6O)m-(C2H4O)nH(1)(n和 )HO - [(C2H4O)n-(C3H6O)m] iH(2)(n,m和1是任意的自然数)
    • 6. 发明申请
    • Drugs containing galectin 9
    • 含有半乳凝素的药物9
    • US20060134119A1
    • 2006-06-22
    • US10543193
    • 2003-08-21
    • Mitsuomi HirashimaNozomu NishiAkira YamauchiNaoko YoshidaMasako Seki
    • Mitsuomi HirashimaNozomu NishiAkira YamauchiNaoko YoshidaMasako Seki
    • A61K48/00A61K38/17A61K39/395
    • A61K38/1709C07K16/18
    • Galectin 9 exerts various functions depending on its localizations. On the other hand, galectin 9 is expected as participating in various biological functions. Thus, it has been required to clarify the detailed biological activities of galectin 9 and develop galectin 9-related techniques including development of drugs. Human galectin 9 shows a cytotoxic activity and an apoptosis-inducing activity on tumor cells but shows neither cytotoxic activity nor apoptosis-inducing activity on normal cells. Therefore, it is possible to employ galectin 9 proteins, galectin 9 agonists, galectin 9 antagonists, anti-galectin 9 binding protein antibodies, anti-galectin 9 binding sugar chain antibodies, galectin 9-producing, releasing or inducing substances, etc. as antitumor, antiallergic, immunosuppressive agents, drugs for autoimmune diseases, anti-inflammatory agents and active ingredients for adrenocortical steroid hormone alternatives.
    • Galectin 9根据其定位具有各种功能。 另一方面,半乳凝素9预期参与各种生物学功能。 因此,需要阐明半乳凝素9的详细生物学活性,并开发包含药物开发的半乳凝素9相关技术。 人半乳凝素9显示对肿瘤细胞的细胞毒活性和细胞凋亡诱导活性,但对正常细胞无细胞毒性活性或细胞凋亡诱导活性。 因此,可以使用半乳凝素9蛋白,半乳凝素9激动剂,半乳凝素9拮抗剂,抗半乳凝素9结合蛋白抗体,抗半乳凝素9结合糖链抗体,半乳凝素-9产生,释放或诱导物质等作为抗肿瘤剂 ,抗过敏药,免疫抑制剂,自身免疫性疾病药物,抗炎药和肾上腺皮质激素替代物的活性成分。